TY - JOUR
T1 - Enhanced validation of antibodies for research applications
AU - Edfors, Fredrik
AU - Hober, Andreas
AU - Linderbäk, Klas
AU - Maddalo, Gianluca
AU - Azimi, Alireza
AU - Sivertsson, Åsa
AU - Tegel, Hanna
AU - Hober, Sophia
AU - Szigyarto, Cristina Al Khalili
AU - Fagerberg, Linn
AU - von Feilitzen, Kalle
AU - Oksvold, Per
AU - Lindskog, Cecilia
AU - Forsström, Björn
AU - Uhlén, Mathias
N1 - Open Access This article is licensed under a Creative Commons Attribution 4.0 International License
PY - 2018
Y1 - 2018
N2 - There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation pillars were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that these principles can be used in a streamlined manner for enhanced validation of research antibodies in Western blot applications. More than 6,000 antibodies were validated with at least one of these strategies involving orthogonal methods, genetic knockdown, recombinant expression, independent antibodies, and capture mass spectrometry analysis. The results show a path forward for efforts to validate antibodies in an application-specific manner suitable for both providers and users.
AB - There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation pillars were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that these principles can be used in a streamlined manner for enhanced validation of research antibodies in Western blot applications. More than 6,000 antibodies were validated with at least one of these strategies involving orthogonal methods, genetic knockdown, recombinant expression, independent antibodies, and capture mass spectrometry analysis. The results show a path forward for efforts to validate antibodies in an application-specific manner suitable for both providers and users.
U2 - 10.1038/s41467-018-06642-y
DO - 10.1038/s41467-018-06642-y
M3 - Journal article
C2 - 30297845
SN - 2041-1723
VL - 9
JO - Nature Communications
JF - Nature Communications
M1 - 4130
ER -